Clinical judgment that matters: We judge progress by more than the scale in month oneappetite stability, reduced cravings, improved portion control, less food noise, better glucose patterns, and tolerability
Many people take GLP-1 medications for 12 months or longer
3.4.3 Weight changes Concerning weight change, Tirzepatide did not demonstrate clear superiority over Semaglutide, with a pooled effect size of 2.57 (95% CI: 6.771.62
20 The researchers didnt find an increased risk for proliferative diabetic retinopathy or for diabetic retinopathy/diabetic macular edema requiring treatment with semaglutide compared to the other GLP-1 RAs or to the non-GLP-1 RA antihyperglycemic medications
The evidence in aging primates is particularly compelling
At Apex MD: Clinical Support Meets Full Coaching Losing weight changes your physical frame, but maintaining it requires an energetic shift in how you live, eat, and move